<code id='B4C0274B3E'></code><style id='B4C0274B3E'></style>
      • <acronym id='B4C0274B3E'></acronym>
      <center id='B4C0274B3E'><center id='B4C0274B3E'><tfoot id='B4C0274B3E'></tfoot></center><abbr id='B4C0274B3E'><dir id='B4C0274B3E'><tfoot id='B4C0274B3E'></tfoot><noframes id='B4C0274B3E'>
      • <optgroup id='B4C0274B3E'><strike id='B4C0274B3E'><sup id='B4C0274B3E'></sup></strike><code id='B4C0274B3E'></code></optgroup>
        5. <b id='B4C0274B3E'><label id='B4C0274B3E'><select id='B4C0274B3E'><dt id='B4C0274B3E'><span id='B4C0274B3E'></span></dt></select></label></b><u id='B4C0274B3E'></u>
          <i id='B4C0274B3E'><strike id='B4C0274B3E'><tt id='B4C0274B3E'><pre id='B4C0274B3E'></pre></tt></strike></i>
          
    
          
      
          
       
      
          
        
      
          
      
          
        
          
          
          
            
          
            
          
              
          
                
          Wikipedia 
          
                
          
                
          
              
          
            
          
            
            
          
          
          
       
        
          
      
          
      
          
        
          
        
          
          
            
          
                           
          Wikipedia  
          
                                   
                 
                                      author：entertainment   
                                        
                                      
                                      Page View：91
                                  
                                    
          
                                    
          CMS Administrator Chiquita Brooks-LaSure																									Chip Somodevilla/Getty Images
          WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.
          Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.
          advertisement
          Pharmaceutical groups and patient advocates are increasingly fighting that approach.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates
                                
                            
          Next article：  
                                      
                                          Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
                                                                    
          
            
          
           
            
          
          
          
       
          
        
          
        
      
          
      
          
                                                
        
          comprehensive
          
                  
          

                    
          
            
          
              
                Drug repurposing or repositioning? The language matters
                
          
                        
              
          
                Drug repurposing or repositioning? The language matters
                
          
                  
          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                An innovative path out of biotech’s “valley of death”
                
          
                        
              
          
                An innovative path out of biotech’s “valley of death”
                
          
                  
          AdobeSomanypromisingmedicalinnovationsneverreachtheirfullpotentialastherapiesorcures,languishinginst
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
                   
          
            
          
              
                George Santos makes 1st court appearance after pleading not guilty to 13 counts
                
          
                        
              
          
                George Santos makes 1st court appearance after pleading not guilty to 13 counts
                
          
                  
          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos
          
                
          
                
                  read more
                    
                  
              
          
            
          
          
          
         
        
          
          
        
          

          
          
            
          
          
          
            
          Novo Nordisk gets FDA approval to tout heart benefits of Wegovy
          
            
          AmandaAndrade-Rhoades/APU.S.regulatorsapprovedalabelexpansionforNovoNordisk’sobesitydrugWegovytotout
          
          
          
          
          
            read more